APO Research
Talk to an analyst

APO RESEARCH · REPORT

Buspirone

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Buspirone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025191 pages

Choose your research edition.

Industry ResearchBuspirone Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Buspirone Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Buspirone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Buspirone Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Buspirone Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Buspirone market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Buspirone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Buspirone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Buspirone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Buspirone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Buspirone include Teva, Novartis, Mylan, Wockhardt, Watson Laboratories, Orion Corporation, Laboratoires Servier, Hikma and Dr. Reddy's Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Buspirone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Buspirone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Buspirone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Buspirone market size, projected growth trends, production technologies, key applications, and end-use industries.

Buspirone Segment by Company

Teva

Novartis

Mylan

Wockhardt

Watson Laboratories

Orion Corporation

Laboratoires Servier

Hikma

Dr. Reddy's Laboratories

Cadila Healthcare

Bristol Myers Squibb

Apotex

AMAG Pharmaceuticals

Buspirone Segment by Type

10mg

15mg

30mg

5mg

Buspirone Segment by Application

Hospital

Drug Store

Buspirone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Buspirone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Buspirone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Buspirone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Buspirone market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Buspirone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Buspirone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Buspirone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Buspirone Industry Trends Table 2. Buspirone Industry Drivers Table 3. Buspirone Industry Opportunities and Challenges Table 4. Buspirone Industry Restraints Table 5. Global Buspirone Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Buspirone Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Buspirone Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Buspirone Sales Market Share by Manufacturers Table 9. Global Buspirone Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Buspirone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Buspirone Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Buspirone Manufacturers, Product Type & Application Table 13. Global Buspirone Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Buspirone by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 10mg Table 17. Major Manufacturers of 15mg Table 18. Major Manufacturers of 30mg Table 19. Major Manufacturers of 5mg Table 20. Global Buspirone Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Buspirone Sales by Type (2021-2026) & (K Units) Table 22. Global Buspirone Sales by Type (2027-2032) & (K Units) Table 23. Global Buspirone Sales Market Share by Type (2021-2026) Table 24. Global Buspirone Sales Market Share by Type (2027-2032) Table 25. Global Buspirone Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Buspirone Revenue by Type (2021-2026) & (K Units) Table 27. Global Buspirone Revenue by Type (2027-2032) & (K Units) Table 28. Global Buspirone Revenue Market Share by Type (2021-2026) Table 29. Global Buspirone Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Drug Store Table 32. Global Buspirone Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Buspirone Sales by Application (2021-2026) & (K Units) Table 34. Global Buspirone Sales by Application (2027-2032) & (K Units) Table 35. Global Buspirone Sales Market Share by Application (2021-2026) Table 36. Global Buspirone Sales Market Share by Application (2027-2032) Table 37. Global Buspirone Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Buspirone Revenue by Application (2021-2026) & (K Units) Table 39. Global Buspirone Revenue by Application (2027-2032) & (K Units) Table 40. Global Buspirone Revenue Market Share by Application (2021-2026) Table 41. Global Buspirone Revenue Market Share by Application (2027-2032) Table 42. Global Buspirone Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Buspirone Sales by Region (2021-2026) & (K Units) Table 44. Global Buspirone Sales Market Share by Region (2021-2026) Table 45. Global Buspirone Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Buspirone Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Buspirone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Buspirone Sales by Country (2021-2026) & (K Units) Table 49. North America Buspirone Sales by Country (2027-2032) & (K Units) Table 50. Europe Buspirone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Buspirone Sales by Country (2021-2026) & (K Units) Table 52. Europe Buspirone Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Buspirone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Buspirone Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Buspirone Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Buspirone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Buspirone Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Buspirone Sales by Country (2027-2032) & (K Units) Table 59. Global Buspirone Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Buspirone Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Buspirone Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Buspirone Revenue Market Share by Region (2021-2026) Table 63. Global Buspirone Revenue Market Share by Region (2027-2032) Table 64. Teva Company Information Table 65. Teva Business Overview Table 66. Teva Buspirone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Teva Buspirone Product Portfolio Table 68. Teva Recent Development Table 69. Novartis Company Information Table 70. Novartis Business Overview Table 71. Novartis Buspirone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Novartis Buspirone Product Portfolio Table 73. Novartis Recent Development Table 74. Mylan Company Information Table 75. Mylan Business Overview Table 76. Mylan Buspirone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Mylan Buspirone Product Portfolio Table 78. Mylan Recent Development Table 79. Wockhardt Company Information Table 80. Wockhardt Business Overview Table 81. Wockhardt Buspirone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Wockhardt Buspirone Product Portfolio Table 83. Wockhardt Recent Development Table 84. Watson Laboratories Company Information Table 85. Watson Laboratories Business Overview Table 86. Watson Laboratories Buspirone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Watson Laboratories Buspirone Product Portfolio Table 88. Watson Laboratories Recent Development Table 89. Orion Corporation Company Information Table 90. Orion Corporation Business Overview Table 91. Orion Corporation Buspirone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Orion Corporation Buspirone Product Portfolio Table 93. Orion Corporation Recent Development Table 94. Laboratoires Servier Company Information Table 95. Laboratoires Servier Business Overview Table 96. Laboratoires Servier Buspirone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Laboratoires Servier Buspirone Product Portfolio Table 98. Laboratoires Servier Recent Development Table 99. Hikma Company Information Table 100. Hikma Business Overview Table 101. Hikma Buspirone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Hikma Buspirone Product Portfolio Table 103. Hikma Recent Development Table 104. Dr. Reddy's Laboratories Company Information Table 105. Dr. Reddy's Laboratories Business Overview Table 106. Dr. Reddy's Laboratories Buspirone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Dr. Reddy's Laboratories Buspirone Product Portfolio Table 108. Dr. Reddy's Laboratories Recent Development Table 109. Cadila Healthcare Company Information Table 110. Cadila Healthcare Business Overview Table 111. Cadila Healthcare Buspirone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Cadila Healthcare Buspirone Product Portfolio Table 113. Cadila Healthcare Recent Development Table 114. Bristol Myers Squibb Company Information Table 115. Bristol Myers Squibb Business Overview Table 116. Bristol Myers Squibb Buspirone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Bristol Myers Squibb Buspirone Product Portfolio Table 118. Bristol Myers Squibb Recent Development Table 119. Apotex Company Information Table 120. Apotex Business Overview Table 121. Apotex Buspirone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Apotex Buspirone Product Portfolio Table 123. Apotex Recent Development Table 124. AMAG Pharmaceuticals Company Information Table 125. AMAG Pharmaceuticals Business Overview Table 126. AMAG Pharmaceuticals Buspirone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. AMAG Pharmaceuticals Buspirone Product Portfolio Table 128. AMAG Pharmaceuticals Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Buspirone Distributors List Table 132. Buspirone Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Buspirone Product Image Figure 2. Global Buspirone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Buspirone Market Size (2021-2032) & (US$ Million) Figure 4. Global Buspirone Sales (2021-2032) & (K Units) Figure 5. Global Buspirone Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Buspirone Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 10mg Image Figure 9. 15mg Image Figure 10. 30mg Image Figure 11. 5mg Image Figure 12. Global Buspirone Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Buspirone Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Buspirone Sales Market Share by Type (2021-2032) Figure 15. Global Buspirone Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Buspirone Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Buspirone Revenue Market Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Drug Store Image Figure 20. Global Buspirone Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Buspirone Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Buspirone Sales Market Share by Application (2021-2032) Figure 23. Global Buspirone Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Buspirone Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Buspirone Revenue Market Share by Application (2021-2032) Figure 26. North America Buspirone Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Buspirone Sales Market Share by Country (2021-2032) Figure 28. U.S. Buspirone Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Buspirone Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Buspirone Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Buspirone Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Buspirone Sales Market Share by Country (2021-2032) Figure 33. Germany Buspirone Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Buspirone Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Buspirone Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Buspirone Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Buspirone Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Buspirone Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Buspirone Sales Market Share by Country (2021-2032) Figure 40. China Buspirone Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Buspirone Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Buspirone Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Buspirone Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Buspirone Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Buspirone Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Buspirone Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Buspirone Sales Market Share by Country (2021-2032) Figure 48. Brazil Buspirone Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Buspirone Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Buspirone Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Buspirone Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Buspirone Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Buspirone Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Buspirone Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Buspirone Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Buspirone Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Buspirone Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Buspirone Revenue (2021-2032) & (US$ Million) Figure 59. North America Buspirone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Buspirone Revenue (2021-2032) & (US$ Million) Figure 61. Europe Buspirone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Buspirone Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Buspirone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Buspirone Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Buspirone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Buspirone Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Buspirone Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg
  • 15mg
  • 30mg
  • 5mg
Applications
  • Hospital
  • Drug Store
Companies covered
  • Teva
  • Novartis
  • Mylan
  • Wockhardt
  • Watson Laboratories
  • Orion Corporation
  • Laboratoires Servier
  • Hikma
  • Dr. Reddy's Laboratories
  • Cadila Healthcare
  • Bristol Myers Squibb
  • Apotex
  • AMAG Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Buspirone Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Buspirone Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Buspirone Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Buspirone Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Buspirone Market Dynamics
  1. 2.1 Buspirone Industry Trends
  2. 2.2 Buspirone Industry Drivers
  3. 2.3 Buspirone Industry Opportunities and Challenges
  4. 2.4 Buspirone Industry Restraints
3 Buspirone Market by Manufacturers
  1. 3.1 Global Buspirone Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Buspirone Sales by Manufacturers (2021-2026)
  3. 3.3 Global Buspirone Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Buspirone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Buspirone Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Buspirone Manufacturers, Product Type & Application
  7. 3.7 Global Buspirone Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Buspirone Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Buspirone Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Buspirone Tier 1, Tier 2, and Tier 3
4 Buspirone Market by Type
  1. 4.1 Buspirone Type Introduction
  2. 4.1.1 10mg
  3. 4.1.2 15mg
  4. 4.1.3 30mg
  5. 4.1.4 5mg
  6. 4.2 Global Buspirone Sales by Type
  7. 4.2.1 Global Buspirone Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Buspirone Sales by Type (2021-2032)
  9. 4.2.3 Global Buspirone Sales Market Share by Type (2021-2032)
  10. 4.3 Global Buspirone Revenue by Type
  11. 4.3.1 Global Buspirone Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Buspirone Revenue by Type (2021-2032)
  13. 4.3.3 Global Buspirone Revenue Market Share by Type (2021-2032)
5 Buspirone Market by Application
  1. 5.1 Buspirone Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drug Store
  4. 5.2 Global Buspirone Sales by Application
  5. 5.2.1 Global Buspirone Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Buspirone Sales by Application (2021-2032)
  7. 5.2.3 Global Buspirone Sales Market Share by Application (2021-2032)
  8. 5.3 Global Buspirone Revenue by Application
  9. 5.3.1 Global Buspirone Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Buspirone Revenue by Application (2021-2032)
  11. 5.3.3 Global Buspirone Revenue Market Share by Application (2021-2032)
6 Global Buspirone Sales by Region
  1. 6.1 Global Buspirone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Buspirone Sales by Region (2021-2032)
  3. 6.2.1 Global Buspirone Sales by Region (2021-2026)
  4. 6.2.2 Global Buspirone Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Buspirone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Buspirone Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Buspirone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Buspirone Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Buspirone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Buspirone Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Buspirone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Buspirone Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Buspirone Revenue by Region
  1. 7.1 Global Buspirone Revenue by Region
  2. 7.1.1 Global Buspirone Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Buspirone Revenue by Region (2021-2026)
  4. 7.1.3 Global Buspirone Revenue by Region (2027-2032)
  5. 7.1.4 Global Buspirone Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Buspirone Revenue (2021-2032)
  8. 7.2.2 North America Buspirone Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Buspirone Revenue (2021-2032)
  11. 7.3.2 Europe Buspirone Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Buspirone Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Buspirone Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Buspirone Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Buspirone Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Buspirone Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Buspirone Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Buspirone Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Buspirone Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Buspirone Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Buspirone Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 Wockhardt
  20. 8.4.1 Wockhardt Company Information
  21. 8.4.2 Wockhardt Business Overview
  22. 8.4.3 Wockhardt Buspirone Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Wockhardt Buspirone Product Portfolio
  24. 8.4.5 Wockhardt Recent Developments
  25. 8.5 Watson Laboratories
  26. 8.5.1 Watson Laboratories Company Information
  27. 8.5.2 Watson Laboratories Business Overview
  28. 8.5.3 Watson Laboratories Buspirone Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Watson Laboratories Buspirone Product Portfolio
  30. 8.5.5 Watson Laboratories Recent Developments
  31. 8.6 Orion Corporation
  32. 8.6.1 Orion Corporation Company Information
  33. 8.6.2 Orion Corporation Business Overview
  34. 8.6.3 Orion Corporation Buspirone Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Orion Corporation Buspirone Product Portfolio
  36. 8.6.5 Orion Corporation Recent Developments
  37. 8.7 Laboratoires Servier
  38. 8.7.1 Laboratoires Servier Company Information
  39. 8.7.2 Laboratoires Servier Business Overview
  40. 8.7.3 Laboratoires Servier Buspirone Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Laboratoires Servier Buspirone Product Portfolio
  42. 8.7.5 Laboratoires Servier Recent Developments
  43. 8.8 Hikma
  44. 8.8.1 Hikma Company Information
  45. 8.8.2 Hikma Business Overview
  46. 8.8.3 Hikma Buspirone Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hikma Buspirone Product Portfolio
  48. 8.8.5 Hikma Recent Developments
  49. 8.9 Dr. Reddy's Laboratories
  50. 8.9.1 Dr. Reddy's Laboratories Company Information
  51. 8.9.2 Dr. Reddy's Laboratories Business Overview
  52. 8.9.3 Dr. Reddy's Laboratories Buspirone Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Dr. Reddy's Laboratories Buspirone Product Portfolio
  54. 8.9.5 Dr. Reddy's Laboratories Recent Developments
  55. 8.10 Cadila Healthcare
  56. 8.10.1 Cadila Healthcare Company Information
  57. 8.10.2 Cadila Healthcare Business Overview
  58. 8.10.3 Cadila Healthcare Buspirone Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Cadila Healthcare Buspirone Product Portfolio
  60. 8.10.5 Cadila Healthcare Recent Developments
  61. 8.11 Bristol Myers Squibb
  62. 8.11.1 Bristol Myers Squibb Company Information
  63. 8.11.2 Bristol Myers Squibb Business Overview
  64. 8.11.3 Bristol Myers Squibb Buspirone Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Bristol Myers Squibb Buspirone Product Portfolio
  66. 8.11.5 Bristol Myers Squibb Recent Developments
  67. 8.12 Apotex
  68. 8.12.1 Apotex Company Information
  69. 8.12.2 Apotex Business Overview
  70. 8.12.3 Apotex Buspirone Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Apotex Buspirone Product Portfolio
  72. 8.12.5 Apotex Recent Developments
  73. 8.13 AMAG Pharmaceuticals
  74. 8.13.1 AMAG Pharmaceuticals Company Information
  75. 8.13.2 AMAG Pharmaceuticals Business Overview
  76. 8.13.3 AMAG Pharmaceuticals Buspirone Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 AMAG Pharmaceuticals Buspirone Product Portfolio
  78. 8.13.5 AMAG Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Buspirone Value Chain Analysis
  2. 9.1.1 Buspirone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Buspirone Production Mode & Process
  6. 9.2 Buspirone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Buspirone Distributors
  9. 9.2.3 Buspirone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst